Ardelyx, Inc. financial data

Symbol
ARDX on Nasdaq
Industry
Pharmaceutical Preparations
Location
34175 Ardenwood Blvd., Fremont, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
NTERYX INC (to 6/9/2008)
Latest financial report
10-Q - Q3 2024 - Oct 31, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 438 % +41.4%
Quick Ratio 124 % +71.4%
Debt-to-equity 117 % +70.2%
Return On Equity -46.6 % -136%
Return On Assets -21.5 % -83.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 237M shares +2.03%
Common Stock, Shares, Outstanding 237M shares +2.05%
Entity Public Float 725M USD +712%
Common Stock, Value, Issued 24K USD +4.35%
Weighted Average Number of Shares Outstanding, Basic 236M shares +5.89%
Weighted Average Number of Shares Outstanding, Diluted 236M shares +3.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 252M USD +87.6%
Cost of Revenue 5.57M USD +6452%
Research and Development Expense 48.2M USD +37%
Costs and Expenses 279M USD +96.9%
Operating Income (Loss) -64.1M USD -177%
Nonoperating Income (Expense) 9.09M USD +94.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -72M USD -173%
Income Tax Expense (Benefit) 564K USD +164%
Net Income (Loss) Attributable to Parent -72.6M USD -173%
Earnings Per Share, Basic -0.3 USD/shares -400%
Earnings Per Share, Diluted -0.3 USD/shares -400%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 47.4M USD +40.5%
Accounts Receivable, after Allowance for Credit Loss, Current 53.2M USD +23%
Inventory, Net 85.2M USD +79.3%
Assets, Current 284M USD +17.8%
Property, Plant and Equipment, Net 1.03M USD -7.89%
Operating Lease, Right-of-Use Asset 3.63M USD -44.4%
Other Assets, Noncurrent 5.33M USD +244%
Assets 368M USD +27.1%
Accounts Payable, Current 15.8M USD +105%
Employee-related Liabilities, Current 11.5M USD +38.1%
Contract with Customer, Liability, Current 7.27M USD +78.6%
Liabilities, Current 70.5M USD +62%
Contract with Customer, Liability, Noncurrent 12.8M USD +24.1%
Operating Lease, Liability, Noncurrent 1.22M USD -57.8%
Other Liabilities, Noncurrent 170K USD
Liabilities 210M USD +113%
Accumulated Other Comprehensive Income (Loss), Net of Tax 185K USD
Retained Earnings (Accumulated Deficit) -890M USD -8.88%
Stockholders' Equity Attributable to Parent 158M USD -17.2%
Liabilities and Equity 368M USD +27.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.7M USD +20.3%
Net Cash Provided by (Used in) Financing Activities 53M USD +4.03%
Net Cash Provided by (Used in) Investing Activities -2.57M USD +73.7%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 237M shares +2.05%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 14.7M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 47.4M USD +40.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.1M USD +144%
Deferred Tax Assets, Valuation Allowance 196M USD +11.7%
Deferred Tax Assets, Gross 198M USD +11.1%
Operating Lease, Liability 3.79M USD -47.5%
Depreciation 232K USD -45%
Payments to Acquire Property, Plant, and Equipment 150K USD +971%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -72.2M USD -171%
Lessee, Operating Lease, Liability, to be Paid 4M USD -47.8%
Property, Plant and Equipment, Gross 11.2M USD +3.03%
Operating Lease, Liability, Current 2.57M USD -40.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 702K USD -51.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.66M USD -64.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 215K USD -52.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 238K USD -27.7%
Deferred Tax Assets, Operating Loss Carryforwards 98.7M USD +14%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 23.6M USD -1.87%
Lessee, Operating Lease, Liability, to be Paid, Year Four 124K USD
Operating Lease, Payments 4.78M USD +8.27%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 435K USD
Deferred Tax Assets, Net of Valuation Allowance 1.36M USD -36.2%
Share-based Payment Arrangement, Expense 31.4M USD +171%
Interest Expense 6.28M USD +70.5%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%